CompanyVNRXNYSEHenderson, NV

Volitionrx Ltd

Volition develops blood tests for early detection and monitoring of cancers and NETosis-associated diseases including sepsis.

SEC EDGAR ClinicalTrials.gov volition.com

8-KSep 25Latest SEC filing

Sep 25Latest story

September 2026

VolitionRx issues shares to Lind to satisfy note conversions

Sep 25FinancingVolitionrx Ltd

VolitionRx issues shares to Lind on convertible note conversions

Sep 15FinancingVolitionrx Ltd

VolitionRx gets waiver from Lind on ATM sales exceeding annual cap

Sep 2PartnershipVolitionrx Ltd

VolitionRx issues shares to Lind Global under convertible note conversions

Sep 1FinancingVolitionrx Ltd

August 2026

VolitionRx issues shares to Lind under existing note conversions

Aug 24FinancingVolitionrx Ltd

VolitionRx reports Q2 2026 results, cites licensing talks and Sysmex collaboration

Aug 13Quarterly updateVolitionrx Ltd

VolitionRx issues shares to Lind to satisfy note payment and conversion obligations

Aug 7FinancingVolitionrx Ltd